| P50 | author | Peter Valent | Q56697676 |
| P2093 | author name string | Wolfgang R Sperr | |
| | Maria-Theresa Krauth | |
| | Hans-Jörg Bühring | |
| | Matthias Mayerhofer | |
| | Dieter Printz | |
| | Gerhard Fritsch | |
| | Stefan Florian | |
| | Alexandra Böhm | |
| | Karl J Aichberger | |
| | Minoo Ghannadan | |
| | Alexander W Hauswirth | |
| | Gerit-Holger Schernthaner | |
| | Michael R Müller | |
| | Christian Sillaber | |
| | Karoline Sonneck | |
| P2860 | cites work | Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis | Q22001442 |
| | A family of proteins that inhibit signalling through tyrosine kinase receptors | Q24336010 |
| | Identification of major binding proteins and substrates for the SH2-containing protein tyrosine phosphatase SHP-1 in macrophages | Q24522530 |
| | SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain | Q24533530 |
| | Signal transduction-associated and cell activation-linked antigens expressed in human mast cells | Q28202019 |
| | Steel factor induces tyrosine phosphorylation of CRKL and binding of CRKL to a complex containing c-kit, phosphatidylinositol 3-kinase, and p120(CBL) | Q28307140 |
| | Signal-regulatory protein alpha (SIRPalpha) but not SIRPbeta is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+)CD38(-) hematopoietic cells. | Q30649377 |
| | Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder | Q33784323 |
| | Diagnostic criteria and classification of mastocytosis: a consensus proposal | Q33948617 |
| | Kit signal transduction | Q33979008 |
| | Interleukin 3 activates human blood basophils via high-affinity binding sites. | Q34291889 |
| | Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor | Q34567286 |
| | Kit and c-kit mutations in mastocytosis: a short overview with special reference to novel molecular and diagnostic concepts. | Q34580164 |
| | The function of the protein tyrosine phosphatase SHP-1 in cancer | Q35092309 |
| | Diagnosis and treatment of systemic mastocytosis: state of the art. | Q35203889 |
| | Mast cell proliferative disorders: current view on variants recognized by the World Health Organization | Q35560203 |
| | Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand | Q36070756 |
| | c-kit ligand: a unique potentiator of mediator release by human lung mast cells | Q36230802 |
| | Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo | Q36366794 |
| | Genetic analysis reveals cell type-specific regulation of receptor tyrosine kinase c-Kit by the protein tyrosine phosphatase SHP1 | Q36367328 |
| | Identification and cloning of ELF-1, a developmentally expressed ligand for the Mek4 and Sek receptor tyrosine kinases | Q36676147 |
| | The growth and differentiation of mast cells | Q36928390 |
| | Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1 | Q37048166 |
| | Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product | Q38315689 |
| | The riddle of the mast cell: kit(CD117)-ligand as the missing link? | Q40388512 |
| | BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin. | Q40695052 |
| | Detection of novel CD antigens on the surface of human mast cells and basophils | Q40731114 |
| | Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cells. | Q40764561 |
| | Signal regulatory proteins negatively regulate immunoreceptor-dependent cell activation. | Q40920164 |
| | Establishment of an immature mast cell line from a patient with mast cell leukemia | Q41296878 |
| | Identification of a ligand for the c-kit proto-oncogene | Q41718674 |
| | The role of CD47 in neutrophil transmigration. Increased rate of migration correlates with increased cell surface expression of CD47. | Q43691944 |
| | Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. | Q43745319 |
| | Spleen colony-forming cell as common precursor for tissue mast cells and granulocytes | Q59060090 |
| P433 | issue | 6 | |
| P921 | main subject | mast cell | Q191989 |
| P304 | page(s) | 984-992 | |
| P577 | publication date | 2005-03-22 | |
| P1433 | published in | Journal of Leukocyte Biology | Q1524048 |
| P1476 | title | Evaluation of normal and neoplastic human mast cells for expression of CD172a (SIRPalpha), CD47, and SHP-1 | |
| P478 | volume | 77 | |